MoneyWorks4Me

Zydus Lifesciences informs about press release

26 Nov 2025 Evaluate
Zydus Lifesciences has enclosed a copy of press release dated November 26, 2025, titled ‘Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..